Hi Guest Login
Home > Tests > BRCA1 & BRCA2 Mutation Detection With??MLPA > Zirakpur
₹28450 ₹22760
Report Time
21 DaysFREE
Home Sample Collection
Age Group
Parameters Included
0
Recomended for
Both
Fasting
No Fasting Required
Report Time
21 Days
Exclusive Offer
₹22760
₹28450
FREE Home Sample Collection*
FREE Smart Report
Get a callback from our Health advisor.
Understanding the Test
Test Measures
City Price Info
The BRCA1 & BRCA2 Mutation Detection with MLPA Test is an advanced genetic screening test designed to identify large deletions and duplications in the BRCA1 and BRCA2 genes, which are strongly associated with hereditary breast and ovarian cancer syndromes. Now accessible to residents across Zirakpur with convenient home sample collection, this test uses MLPA technology to detect structural genetic changes that may not be identified through conventional sequencing alone. The results help assess inherited cancer risk, support early detection and prevention strategies, guide personalized treatment decisions, and provide valuable information for genetic counselling and family risk assessment.
The BRCA1 & BRCA2 test evaluates structural and copy-number variants in the BRCA genes, which play a critical role in repairing damaged DNA and maintaining genetic stability. Mutations, deletions, or duplications in these genes can impair normal DNA repair mechanisms, increasing the risk of developing certain hereditary cancers. Ensuring this advanced diagnostic tool is readily available for patients in Zirakpur, the test detects alterations in the BRCA1 gene, including deletions and duplications associated with a significantly higher risk of breast, ovarian, and other cancers. It also identifies BRCA2 gene mutations, which can affect DNA repair and tumour suppression functions, helping assess an individual's inherited cancer risk and guide preventive or treatment decisions.
Helps detect risk of:
The BRCA1 & BRCA2 Mutation Detection Test uses the MLPA method to detect structural variants, such as deletions and duplications, in the BRCA1 and BRCA2 genes.
These genes play a critical role in repairing damaged DNA and maintaining genomic stability. Mutations in these genes disrupt DNA repair and significantly increase the lifetime risk of cancers, especially breast and ovarian cancer.
MLPA (Multiplex Ligation-dependent Probe Amplification) is a highly sensitive molecular technique that detects large gene rearrangements that standard sequencing methods may miss. This makes it an essential tool in comprehensive genetic cancer screening.
|
Parameter |
Details |
|
Test Name |
BRCA1 & BRCA2 Mutation Detection (MLPA) |
|
Also Known As |
BRCA Genetic Test, Hereditary Cancer Screening |
|
Sample Type |
Blood |
|
Gender |
Both (higher relevance in females) |
|
Age Group |
Adults / High-risk individuals |
|
Fasting Required |
No |
|
Home Collection |
Available |
Proper collection, storage, and transport are essential. Poor handling or delays can affect test accuracy.
Some variants may have unclear significance. Interpretation depends on evolving scientific data and expert analysis.
Different methods have varying sensitivity. MLPA detects large changes, while smaller mutations may need additional testing.
An incomplete or incorrect family history can impact risk assessment and result interpretation.
Rare variants may not be fully understood and can be reported as VUS (uncertain significance).
Previous reports can influence interpretation. Sharing past results ensures a more accurate assessment.
|
Result |
Interpretation |
|
Negative |
No detectable BRCA mutation; standard population risk |
|
Positive |
Mutation detected; increased cancer risk requiring preventive care |
|
Variant of Uncertain Significance (VUS) |
Genetic change detected but unclear clinical significance |
A positive result does not confirm cancer but suggests a higher risk. Preventive strategies such as increased screening, lifestyle modifications, or medical interventions might be advised.
Note: Genetic counselling is strongly advised for accurate interpretation and next steps.
Your reports are carefully processed using advanced genetic testing techniques to ensure high accuracy and reliability. Each report is reviewed by qualified experts before being shared
Take a proactive step towards your health with early genetic risk detection. Understanding your BRCA status helps you make informed decisions about cancer screening, prevention, and treatment.
Read More
You've selected items to compare.
View All